For the quarter ending 2026-03-31.
| Income Statement | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|
| Revenue from government contract | 0 | 0 | 0 | 852,282 |
| Research and development | 3,903,463 | 2,994,429 | 5,043,504 | 4,728,998 |
| General and administrative | 1,369,418 | 1,447,327 | 1,329,711 | 1,542,190 |
| Total operating expenses | 5,272,881 | 4,441,756 | 6,373,215 | 6,271,188 |
| Loss from operations | -5,272,881 | -4,441,756 | -6,373,215 | -5,418,906 |
| Interest income | 10,960 | 23,333 | 54,301 | 49,123 |
| Interest expense | - | 0 | 0 | 0 |
| Total other income (expense) | - | 23,333 | 54,301 | 49,123 |
| Net loss | -5,261,921 | -4,418,423 | -6,318,914 | -5,369,783 |
| Basic EPS | -2.62 | -4.61 | -0.31 | -0.35 |
| Basic Average Shares | 2,008,134 | 958,443* | 20,287,203 | 15,359,220 |
GeoVax Labs, Inc. (GOVX)
GeoVax Labs, Inc. (GOVX)